Intermediate-dose busulfan and cyclophosphamide as a conditioning regimen for bone marrow transplantation in a case of Fanconi anemia in myelodysplastic transformation

A. A. Maschan, O. I. Kryzanovskii, M. I. Yourlova, E. V. Skorobogatova, E. D. Pashanov, Y. E. Potapova, L. A. Timonova, Natalia Bogatcheva, E. V. Samochatova, A. G. Roumjantzev

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

We report an 11-year old female with myelodysplastic (refractory anemia with excess of blasts) presentation of Fanconi anemia. After failure of initial chemotherapy with low doses of 6-mercaptopurine and prednisolone she underwent allogeneic bone marrow transplantation (BMT) from her HLA-matched sibling. Busulfan 8 mg/kg and cyclophosphamide 40 mg/kg were used as conditioning. The post-transplant course was uneventful with fast trilineage engraftment and mild cutaneous acute GVHD. She is alive 17 months after BMT with full hematological reconstitution without evidence of MDS.

Original languageEnglish (US)
Pages (from-to)385-387
Number of pages3
JournalBone Marrow Transplantation
Volume19
Issue number4
StatePublished - Feb 2 1997
Externally publishedYes

Fingerprint

Fanconi Anemia
Busulfan
Bone Marrow Transplantation
Cyclophosphamide
Refractory Anemia with Excess of Blasts
6-Mercaptopurine
Homologous Transplantation
Prednisolone
Transplants
Drug Therapy
Skin

Keywords

  • Bone marrow transplantation
  • Fanconi anemia
  • Myelodysplastic transformation

ASJC Scopus subject areas

  • Hematology
  • Transplantation

Cite this

Maschan, A. A., Kryzanovskii, O. I., Yourlova, M. I., Skorobogatova, E. V., Pashanov, E. D., Potapova, Y. E., ... Roumjantzev, A. G. (1997). Intermediate-dose busulfan and cyclophosphamide as a conditioning regimen for bone marrow transplantation in a case of Fanconi anemia in myelodysplastic transformation. Bone Marrow Transplantation, 19(4), 385-387.

Intermediate-dose busulfan and cyclophosphamide as a conditioning regimen for bone marrow transplantation in a case of Fanconi anemia in myelodysplastic transformation. / Maschan, A. A.; Kryzanovskii, O. I.; Yourlova, M. I.; Skorobogatova, E. V.; Pashanov, E. D.; Potapova, Y. E.; Timonova, L. A.; Bogatcheva, Natalia; Samochatova, E. V.; Roumjantzev, A. G.

In: Bone Marrow Transplantation, Vol. 19, No. 4, 02.02.1997, p. 385-387.

Research output: Contribution to journalArticle

Maschan, AA, Kryzanovskii, OI, Yourlova, MI, Skorobogatova, EV, Pashanov, ED, Potapova, YE, Timonova, LA, Bogatcheva, N, Samochatova, EV & Roumjantzev, AG 1997, 'Intermediate-dose busulfan and cyclophosphamide as a conditioning regimen for bone marrow transplantation in a case of Fanconi anemia in myelodysplastic transformation', Bone Marrow Transplantation, vol. 19, no. 4, pp. 385-387.
Maschan, A. A. ; Kryzanovskii, O. I. ; Yourlova, M. I. ; Skorobogatova, E. V. ; Pashanov, E. D. ; Potapova, Y. E. ; Timonova, L. A. ; Bogatcheva, Natalia ; Samochatova, E. V. ; Roumjantzev, A. G. / Intermediate-dose busulfan and cyclophosphamide as a conditioning regimen for bone marrow transplantation in a case of Fanconi anemia in myelodysplastic transformation. In: Bone Marrow Transplantation. 1997 ; Vol. 19, No. 4. pp. 385-387.
@article{926e59a19eb14eb78604e33a768c3bfe,
title = "Intermediate-dose busulfan and cyclophosphamide as a conditioning regimen for bone marrow transplantation in a case of Fanconi anemia in myelodysplastic transformation",
abstract = "We report an 11-year old female with myelodysplastic (refractory anemia with excess of blasts) presentation of Fanconi anemia. After failure of initial chemotherapy with low doses of 6-mercaptopurine and prednisolone she underwent allogeneic bone marrow transplantation (BMT) from her HLA-matched sibling. Busulfan 8 mg/kg and cyclophosphamide 40 mg/kg were used as conditioning. The post-transplant course was uneventful with fast trilineage engraftment and mild cutaneous acute GVHD. She is alive 17 months after BMT with full hematological reconstitution without evidence of MDS.",
keywords = "Bone marrow transplantation, Fanconi anemia, Myelodysplastic transformation",
author = "Maschan, {A. A.} and Kryzanovskii, {O. I.} and Yourlova, {M. I.} and Skorobogatova, {E. V.} and Pashanov, {E. D.} and Potapova, {Y. E.} and Timonova, {L. A.} and Natalia Bogatcheva and Samochatova, {E. V.} and Roumjantzev, {A. G.}",
year = "1997",
month = "2",
day = "2",
language = "English (US)",
volume = "19",
pages = "385--387",
journal = "Bone Marrow Transplantation",
issn = "0268-3369",
publisher = "Nature Publishing Group",
number = "4",

}

TY - JOUR

T1 - Intermediate-dose busulfan and cyclophosphamide as a conditioning regimen for bone marrow transplantation in a case of Fanconi anemia in myelodysplastic transformation

AU - Maschan, A. A.

AU - Kryzanovskii, O. I.

AU - Yourlova, M. I.

AU - Skorobogatova, E. V.

AU - Pashanov, E. D.

AU - Potapova, Y. E.

AU - Timonova, L. A.

AU - Bogatcheva, Natalia

AU - Samochatova, E. V.

AU - Roumjantzev, A. G.

PY - 1997/2/2

Y1 - 1997/2/2

N2 - We report an 11-year old female with myelodysplastic (refractory anemia with excess of blasts) presentation of Fanconi anemia. After failure of initial chemotherapy with low doses of 6-mercaptopurine and prednisolone she underwent allogeneic bone marrow transplantation (BMT) from her HLA-matched sibling. Busulfan 8 mg/kg and cyclophosphamide 40 mg/kg were used as conditioning. The post-transplant course was uneventful with fast trilineage engraftment and mild cutaneous acute GVHD. She is alive 17 months after BMT with full hematological reconstitution without evidence of MDS.

AB - We report an 11-year old female with myelodysplastic (refractory anemia with excess of blasts) presentation of Fanconi anemia. After failure of initial chemotherapy with low doses of 6-mercaptopurine and prednisolone she underwent allogeneic bone marrow transplantation (BMT) from her HLA-matched sibling. Busulfan 8 mg/kg and cyclophosphamide 40 mg/kg were used as conditioning. The post-transplant course was uneventful with fast trilineage engraftment and mild cutaneous acute GVHD. She is alive 17 months after BMT with full hematological reconstitution without evidence of MDS.

KW - Bone marrow transplantation

KW - Fanconi anemia

KW - Myelodysplastic transformation

UR - http://www.scopus.com/inward/record.url?scp=0031050721&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031050721&partnerID=8YFLogxK

M3 - Article

C2 - 9051250

AN - SCOPUS:0031050721

VL - 19

SP - 385

EP - 387

JO - Bone Marrow Transplantation

JF - Bone Marrow Transplantation

SN - 0268-3369

IS - 4

ER -